Nemesis Bioscience is a biopharmaceutical company developing Nemesis Symbiotics© - DNA therapeutics administered before antibiotics to inactivate resistance in bacterial pathogens.
These Nemesis Symbiotics© will make existing antibiotics work again, prevent the spread of resistance genes and so also protect the efficacy of new antibiotics.
The technology is applicable to all antibiotic classes, all known resistance mechanisms and all bacteria.
Other applications include reduction of chemotherapeutic toxicity, inactivation of virulence factors and in vivo synthesis of biofuels and therapeutics.
The company was awarded the King’s College, Cambridge Entrepreneurship Award for 2014 and has filed patent applications internationally on its inventions.
NEMESIS BIOSCIENCE LTD is a biotechnology company based on th Babraham Research Campus, Cambridge, CB22 3AT, UK
Company Details
- Founded
- -
- Address
- Babraham Research Campus, Maia B270,united Kingdom
- Phone
- 4401223804075
- in****@****bio.com
- Industry
- Biotechnology
- Website
- nemesisbio.com
- HQ
- Cambridge, Cambridgeshire
Nemesis Bioscience Ltd Questions
Nemesis Bioscience Ltd's helpline number is 4401223804075
Nemesis Bioscience Ltd's website is nemesisbio.com
Nemesis Bioscience Ltd's LinkedIn profile is https://uk.linkedin.com/company/nemesis-bioscience-ltd
Nemesis Bioscience Ltd's industry is
Biotechnology
Nemesis Bioscience Ltd's top competitors are
Labgenius Therapeutics,
Biohm | The Future Of Home,
Mach Fm Corp.,
Charnwood Discovery - Formerly Aurelia Bioscience,
Synthase,
Innovation Centre In Digital Molecular Technologies,
Weizmann Uk,
Synomics,
Engitix Therapeutics,
Catapult Therapeutics.
Nemesis Bioscience Ltd's support email address is info@nemesisbio.com
Nemesis Bioscience Ltd's categories are Biotechnology
Nemesis Bioscience Ltd's founding year is 2014
